13F HOLDINGS REPORT
HealthInvest Partners AB
Quarter ended Q1 2024 · Filed April 25, 2024 · Accession 0001381843-24-000004
Total Value
$164.4M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERCK & CO INC | MRK | 133,741 | $17.6M | 10.74% |
| 2 | ELI LILLY & CO | LLY | 20,778 | $16.2M | 9.84% |
| 3 | UNITEDHEALTH GROUP INC | UNH | 23,041 | $11.4M | 6.94% |
| 4 | THERMO FISHER SCIENTIFIC INC | TMO | 15,186 | $8.8M | 5.37% |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 43,480 | $6.0M | 3.65% |
| 6 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 170,000 | $5.7M | 3.47% |
| 7 | STRYKER CORPORATION | SYK | 15,154 | $5.4M | 3.30% |
| 8 | AMGEN INC | AMGN | 18,891 | $5.4M | 3.27% |
| 9 | ABBVIE INC | ABBV | 29,346 | $5.3M | 3.25% |
| 10 | BOSTON SCIENTIFIC CORP | BSX | 77,401 | $5.3M | 3.23% |
| 11 | REGENERON PHARMACEUTICALS | REGN | 5,393 | $5.2M | 3.16% |
| 12 | CENCORA INC | COR | 20,426 | $5.0M | 3.02% |
| 13 | MOLINA HEALTHCARE INC | MOH | 12,000 | $4.9M | 3.00% |
| 14 | VERTEX PHARMACEUTICALS INC | VRTX | 11,295 | $4.7M | 2.87% |
| 15 | OPTION CARE HEALTH INC | OPCH | 132,895 | $4.5M | 2.71% |
| 16 | ELEVANCE HEALTH INC | ELV | 7,400 | $3.8M | 2.33% |
| 17 | GILEAD SCIENCES INC | GILD | 52,000 | $3.8M | 2.32% |
| 18 | DEXCOM INC | DXCM | 26,283 | $3.6M | 2.22% |
| 19 | MIRUM PHARMACEUTICALS INC | MIRM | 123,000 | $3.1M | 1.88% |
| 20 | CARDINAL HEALTH INC | CAH | 27,500 | $3.1M | 1.87% |
| 21 | AMICUS THERAPEUTICS INC | FOLD | 252,307 | $3.0M | 1.81% |
| 22 | FUSION PHARMACEUTICALS INC | 36118A100 | 138,836 | $3.0M | 1.80% |
| 23 | IONIS PHARMACEUTICALS INC | IONS | 63,791 | $2.8M | 1.68% |
| 24 | IMMUNOCORE HLDGS PLC | IMCR | 40,899 | $2.7M | 1.62% |
| 25 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 38,050 | $2.6M | 1.60% |
| 26 | IQVIA HLDGS INC | IQV | 10,058 | $2.5M | 1.55% |
| 27 | EDWARDS LIFESCIENCES CORP | EW | 24,775 | $2.4M | 1.44% |
| 28 | SHOCKWAVE MED INC | 82489T104 | 4,751 | $1.5M | 0.94% |
| 29 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 38,000 | $1.5M | 0.91% |
| 30 | CABALETTA BIO INC | CABA | 77,540 | $1.3M | 0.80% |
| 31 | ARCELLX INC | ACLX | 17,496 | $1.2M | 0.74% |
| 32 | KRYSTAL BIOTECH INC | KRYS | 6,624 | $1.2M | 0.72% |
| 33 | BRIDGEBIO PHARMA INC | BBIO | 37,841 | $1.2M | 0.71% |
| 34 | EXACT SCIENCES CORP | 30063P105 | 16,120 | $1.1M | 0.68% |
| 35 | MERUS N V | N5749R100 | 24,325 | $1.1M | 0.67% |
| 36 | INSPIRE MED SYS INC | 457730109 | 4,782 | $1.0M | 0.62% |
| 37 | CYTOKINETICS INC | CYTK | 14,000 | $981,540 | 0.60% |
| 38 | MADRIGAL PHARMACEUTICALS INC | MDGL | 3,539 | $945,055 | 0.58% |
| 39 | MACROGENICS INC | MGNX | 49,307 | $725,799 | 0.44% |
| 40 | AKERO THERAPEUTICS INC | 00973Y108 | 24,432 | $617,152 | 0.38% |
| 41 | AUTOLUS THERAPEUTICS PLC | AUTL | 96,345 | $614,681 | 0.37% |
| 42 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 22,394 | $529,618 | 0.32% |
| 43 | MORPHIC HLDG INC | 61775R105 | 14,952 | $526,310 | 0.32% |
| 44 | MERSANA THERAPEUTICS INC | 59045L106 | 100,000 | $448,000 | 0.27% |